RPAM
Rhenman & Partners Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Hold |
647,827
| – | – | 0.14% | 85 |
|
|
2025
Q1 | $2.16M | Sell |
647,827
-587,621
| -48% | -$1.96M | 0.25% | 69 |
|
|
2024
Q4 | $9.14M | Buy |
1,235,448
+182,948
| +17% | +$1.35M | 0.94% | 40 |
|
|
2024
Q3 | $9.88M | Buy |
1,052,500
+132,500
| +14% | +$1.24M | 0.8% | 43 |
|
|
2024
Q2 | $7.38M | Sell |
920,000
-35,000
| -4% | -$281K | 0.71% | 42 |
|
|
2024
Q1 | $14.2M | Sell |
955,000
-161,818
| -14% | -$2.4M | 1.34% | 28 |
|
|
2023
Q4 | $9.08M | Buy |
1,116,818
+166,818
| +18% | +$1.36M | 0.91% | 41 |
|
|
2023
Q3 | $4.32M | Buy |
950,000
+100,000
| +12% | +$455K | 0.47% | 54 |
|
|
2023
Q2 | $5.98M | Buy |
850,000
+163,830
| +24% | +$1.15M | 0.63% | 50 |
|
|
2023
Q1 | $4.22M | Sell |
686,170
-178,208
| -21% | -$1.1M | 0.46% | 60 |
|
|
2022
Q4 | $5.52M | Buy |
864,378
+354,378
| +69% | +$2.26M | 0.58% | 57 |
|
|
2022
Q3 | $4.76M | Sell |
510,000
-20,000
| -4% | -$187K | 0.5% | 60 |
|
|
2022
Q2 | $5.85M | Buy |
530,000
+55,000
| +12% | +$607K | 0.66% | 49 |
|
|
2022
Q1 | $7.91M | Sell |
475,000
-125,000
| -21% | -$2.08M | 0.78% | 47 |
|
|
2021
Q4 | $11.7M | Buy |
600,000
+280,000
| +88% | +$5.44M | 0.77% | 47 |
|
|
2021
Q3 | $7.89M | Buy |
320,000
+20,000
| +7% | +$493K | 0.55% | 55 |
|
|
2021
Q2 | $7.81M | Buy |
300,000
+5,000
| +2% | +$130K | 0.53% | 64 |
|
|
2021
Q1 | $9.34M | Sell |
295,000
-25,000
| -8% | -$792K | 0.65% | 51 |
|
|
2020
Q4 | $14.8M | Sell |
320,000
-20,000
| -6% | -$928K | 1.21% | 36 |
|
|
2020
Q3 | $11.2M | Hold |
340,000
| – | – | 1% | 41 |
|
|
2020
Q2 | $9.33M | Sell |
340,000
-25,000
| -7% | -$686K | 1.01% | 40 |
|
|
2020
Q1 | $10.9M | Sell |
365,000
-110,000
| -23% | -$3.29M | 1.53% | 26 |
|
|
2019
Q4 | $13.1M | Sell |
475,000
-45,000
| -9% | -$1.25M | 1.44% | 28 |
|
|
2019
Q3 | $9.46M | Sell |
520,000
-230,700
| -31% | -$4.2M | 1.19% | 35 |
|
|
2019
Q2 | $18.4M | Sell |
750,700
-128,900
| -15% | -$3.16M | 2.03% | 17 |
|
|
2019
Q1 | $8.37M | Sell |
879,600
-325,895
| -27% | -$3.1M | 0.98% | 45 |
|
|
2018
Q4 | $10.7M | Sell |
1,205,495
-85,000
| -7% | -$752K | 1.22% | 39 |
|
|
2018
Q3 | $14.5M | Buy |
1,290,495
+443,019
| +52% | +$4.98M | 1.45% | 32 |
|
|
2018
Q2 | $10.8M | Sell |
847,476
-96,709
| -10% | -$1.24M | 1.11% | 43 |
|
|
2018
Q1 | $16M | Hold |
944,185
| – | – | 1.97% | 21 |
|
|
2017
Q4 | $7.55M | Buy |
944,185
+233,022
| +33% | +$1.86M | 1.02% | 39 |
|
|
2017
Q3 | $5.51M | Buy |
711,163
+61,163
| +9% | +$474K | 0.7% | 57 |
|
|
2017
Q2 | $4.78M | Hold |
650,000
| – | – | 0.69% | 55 |
|
|
2017
Q1 | $4.84M | Hold |
650,000
| – | – | 0.77% | 50 |
|
|
2016
Q4 | $4.52M | Hold |
650,000
| – | – | 0.87% | 45 |
|
|
2016
Q3 | $5.35M | Hold |
650,000
| – | – | 0.85% | 43 |
|
|
2016
Q2 | $5.27M | Buy |
650,000
+50,000
| +8% | +$405K | 0.93% | 42 |
|
|
2016
Q1 | $3.05M | Buy |
600,000
+25,000
| +4% | +$127K | 0.61% | 59 |
|
|
2015
Q4 | $4.44M | Sell |
575,000
-108,108
| -16% | -$835K | 0.67% | 54 |
|
|
2015
Q3 | $3.94M | Buy |
683,108
+127,108
| +23% | +$732K | 0.63% | 59 |
|
|
2015
Q2 | $5.1M | Buy |
+556,000
| New | +$5.1M | 0.61% | 57 |
|